Clinical trial
Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior…
NCT00057005 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00057005 |
|---|---|
| Title | Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation |
| Official title | Phase I Study of Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation (ADVL) |
| Acronym | ADVL |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | The Methodist Hospital Research Institute Center for Cell and Gene Therapy, Baylor College of Medicine |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | LEUKEMIA |
| Intervention type | Drug, Radiation |
| Interventions | CAMPATH-1H, Anti-CD45, Ara-C, Cyclophosphamide, Mesna, Total Body Irradiation |
| Enrollment | 6 |
| Start date | Feb 1, 2003 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Mar 28, 2003 |
| Last update posted | Jan 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: